Back to Top Skip to main content

USS Nimitz certified to administer CCP

Image of USS Nimitz Aircraft carrier USS Nimitz (CVN 68) departs Naval Air Station North Island June 8. Nimitz and elements of the Nimitz Carrier Strike Group (CSG), deployed from San Diego in support of global maritime security operations. (Photo by Navy Petty Officer Second Class Jessica Paulauskas, U.S. 3rd Fleet)

Recommended Content:

Convalescent Plasma Collection Program | Coronavirus | Combat Support

The COVID-19 Convalescent Plasma Collection Program (CCP) is a Department of Defense effort to collect 10,000 units of convalescent plasma donated by members of the military community who have recovered from the disease. Convalescent plasma will be used to treat critically ill patients and to support the development of an effective treatment against the disease. Eligible donors should contact the Armed Services Blood Program at https://www.militaryblood.dod.mil/Donors/COVID-19andBloodDonation.aspx to find a complete list of available collection centers.

The U.S. Army Medical Research and Development Command approved the Nimitz-class aircraft carrier USS Nimitz (CVN 68) as an authorized site to administer COVID-19 Convalescent Plasma, July 16.

CCP is the liquid part of blood collected from patients who recovered from a COVID-19 infection. Antibodies present in convalescent plasma are proteins that help patients fight an active infection; in this case, SARS-CoV-2, the virus that causes COVID-19. Anecdotal evidence suggests that CCP may be an effective treatment for some COVID-19 patients, but it has yet to be clinically proven.

Nimitz received 20 units of CCP from Naval Hospital Guam during a Safe Haven port visit to Guam on June 27. The CCP units Nimitz received are part of an effort by the Department of Defense to collect plasma from COVID-19 patients who have successfully recovered from the illness.

Close up image of USS Nimitz
Aircraft carrier USS Nimitz (CVN 68) departs Naval Air Station North Island June 8. Nimitz and elements of the Nimitz Carrier Strike Group (CSG), deployed from San Diego in support of global maritime security operations. (Photo by Navy Petty Officer Second Class Natalie Byers, U.S. 3rd Fleet)

“We are the first ship to get official approval of the protocol,” said Navy Lt. Heather Hernandez, the ship’s nurse and member of the COVID Response Team aboard the Nimitz. “We could administer plasma today if it was needed. We are following the Army’s protocol for administering plasma and have added an addendum to their protocol, so we are included. We have also tailored the protocol so it fits in with our capabilities on the ship.”

CCP will be available for treatment of COVID-positive patients in DOD treatment facilities and operating units who meet established criteria and in accordance with approved protocols.

“Our plasma was drawn from Sailors aboard USS Theodore Roosevelt (CVN 71) who voluntarily donated their plasma as part of this program,” said Navy Capt. Gilbert Seda, head of the COVID Response Team aboard the Nimitz. “The plasma was checked for the presence of COVID antibodies and then underwent safety checks to ensure it was clean of any other viruses or infections.”

“If we believe a patient is acutely ill, we have the option of administering the plasma and enrolling them in this program,” said Hernandez. “It is optional for the patient to have the plasma administered, and there currently isn’t proof it will make them better.”

Hernandez said that Sailors who enroll in the program and receive CCP, will be enrolled in a 31-day study to track the effects of CCP and follow their recovery, even after they leave the ship.

“This is one treatment available in our repertoire of treatments,” said Seda. “There are a number of other treatments we will provide, and this will not interfere with any of those. Our priority is still to get these patients off the ship.”

Hernandez said the main goal on board the Nimitz is prevention. Mitigation efforts to prevent the disease, including wearing face masks, social distancing, increased ship-wide cleaning, and a focus on handwashing, have all been implemented throughout the entire Nimitz strike group since April. No sailors or Marines within the strike group have been diagnosed with COVID since departing on deployment.

USS Nimitz is the flagship of Nimitz Carrier Strike Group and is deployed conducting maritime security operations and theater security cooperation efforts.

You also may be interested in...

Force Health Protection Guidance (Supplement 12) -Department of Defense Guidance for Personnel Traveling During the Coronavirus Disease 2019 Pandemic

Publication
8/6/2020

This memorandum supplements requirements in references (a), (b), and (c) with respect to coronavirus disease 2019 (COVID-19), and replaces reference (d). It provides pre- and post­travel guidance for purposes of force health protection (FHP) of Service members, DoD family members, DoD civilian employees, and DoD contractor personnel.

Recommended Content:

Coronavirus

Supplemental Guidance 10 for Military Medical Treatment Facilities and Military Dental Treatment Facilities Directors in regards to Coronavirus Disease 2019

Publication
7/1/2020

Recommended Content:

Coronavirus

Pharmacy Operations Division (POD) Reverse HPCON Status Guidance

Publication
6/24/2020

Guidance for Outpatient MTF Pharmacies in Response to COVID-19

Recommended Content:

Coronavirus | COVID Pharmacy Guidance

Download Letter to Beneficiaries

Publication
6/24/2020

This message replaces guidance issued on March 31. It explains actions military pharmacies are taking to keep services and visits safe during the COVID-19 pandemic, and it outlines your pharmacy options as a TRICARE beneficiary.

Recommended Content:

Coronavirus | COVID Pharmacy Guidance | TRICARE Health Program

Communication to ABA Providers Regarding Continued Temporary Authorization to Utilize Telehealth for CPT Code 97156 During the COVID-19 National Emergency

Publication
6/3/2020

TRICARE is announcing the continuation of the temporary exception to policy regarding the use of synchronous telehealth (TH) capabilities (both audio and video) for Applied Behavior Analysis (ABA) Family Adaptive Behavior Treatment Guidance services specifically during this COVID-19 pandemic.

Recommended Content:

Autism Care Demonstration | Coronavirus | TRICARE Health Program

Force Health Protection Guidance (Supplement 9) -Department of Defense Guidance for Deployment and Redeployment of Individuals and Units during the Novel Coronavirus Disease 2019 Pandemic

Publication
5/26/2020

This memorandum provides force health protection (FHP) deployment and redeployment guidance for Service members (including Reserve Component (RC) and National Guard members in a title 10 or title 32 duty status) and DoD civilian employees deploying within and outside the United States during the COVID-19 pandemic, consistent with references (a) and (b).

Recommended Content:

Coronavirus

Guidance for Commanders on Risk-Based Changing of Health Protection Condition Levels During the Coronavirus Disease 2019 Pandemic

Publication
5/20/2020

This memorandum provides guidance for commanders to consider when making decisions to change health protection condition (HPCON) levels as COVID-19 pandemic conditions on and adjacent to our installations begin to improve.

Recommended Content:

Coronavirus

Resuming Elective Surgical, Invasive, and Dental Procedures in Military Medical and Dental Treatment Facilities

Publication
5/19/2020

This memorandum provides guidance on how each Military Medical Treatment Facility (MTF) and Dental Treatment Facility (DTF) may resume elective medical and dental procedures.

Recommended Content:

Public Health | Coronavirus

Modification and Reissuance of DoD Response to Coronavirus Disease 2019 -Travel Restrictions

Publication
4/20/2020

All DoD Service members will stop movement, both internationally and domestically, while this memorandum is in effect. All DoD civilian personnel, and dependents of DoD Service members and DoD civilian personnel, whose travel is Government-funded will stop movement, both internationally and domestically, while this memorandum is in effect.

Recommended Content:

Coronavirus

Implementation Guidance for Presidential Memorandum, "Providing Federal Support for Governor's Use of the National Guard to Respond to COVID-19 ," Dated April 7, 2020

Publication
4/14/2020

Recommended Content:

Coronavirus

Benefits Eligibility for 32 USC 502(f) Missions

Publication
4/14/2020

A chart outlining the various Benefits Eligibility for 32 USC 502(f) Missions

Recommended Content:

Coronavirus | TRICARE Health Program

Memorandum on Providing Federal Support for Governors' Use of the National Guard to Respond to COVID-19

Publication
4/14/2020

Recommended Content:

Coronavirus

Delegation of Authority for Reserve Component Activation Authorities during the Coronavirus Disease 2019 Response

Publication
4/10/2020

This delegation assigns to the Service Secretaries the authority to activate Reserve Component personnel and to modify their orders as needed to employ and retain them for the COVID-19 response.

Recommended Content:

Coronavirus

Authorization to Employ Military Medical Capabilities to Treat COVID-19 Patients

Publication
4/8/2020

Effective immediately, the Commander, U.S Northern Command, is authorized, as he deems necessary and appropriate, to employ military medical capabilities under his operational control to treat patients who have contracted coronavirus disease 2019 (COVID-19).

Recommended Content:

Coronavirus

Decision Memorandum on TRICARE Implementation of the "Families First Coronavirus Response Act"

Publication
4/7/2020

The Families First Coronavirus Response Act, Public Law 116-127, Division F, Section 6006(a), limits TRICARE authority to impose copayment or other cost-sharing for novel coronavirus (COVID-19) testing and related provider visits that result in orders for or administration of Food and Drug Administration (FDA) approved, cleared, or authorized diagnostic products. In order for the Defense Health Agency (DHA) to implement, the Assistant Secretary of Defense for Health Affairs (ASD(HA)) must acknowledge the self-executing authority of the statute and direct the Director, DHA, or designee, to issue guidance implementing the statutory provisions.

Recommended Content:

TRICARE Health Program | Coronavirus
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.